Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Weight Gain and ANKK1[original query] |
---|
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. The Journal of clinical psychiatry 2012 Aug 73 (8): 1077-86. Houston John P, Kohler Jared, Bishop Jeffrey R, Ellingrod Vicki L, Ostbye Katherine M, Zhao Fangyi, Conley Robert R, Poole Hoffmann Vicki, Fijal Bonnie |
Impulsivity and genetic variants in DRD2 and ANKK1 moderate longitudinal associations between sleep problems and overweight from ages 5 to 11. International journal of obesity (2005) 2014 Mar 38 (3): 404-10. Chan T W S, Bates J E, Lansford J E, Dodge K A, Pettit G S, Dick D M, Latendresse S |
Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2015 Mar . Li Hongliang, Wang Xueding, Zhou Yafang, Ni Guanzhong, Su Qibiao, Chen Ziyi, Chen Zhuojia, Li Jiali, Chen Xinmeng, Hou Xiangyu, Xie Wen, Xin Shuang, Zhou Liemin, Huang M |
Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period. Neurology and therapy 2022 11 12 (1): 197-209. Ma Jiuhong, Fan Xiuzhao, Cai Xinfeng, Ji Hongming, Li Yuanping, Guo Jinl |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: